Conditions: Metabolic Syndrome X
Keywords: rosuvastatin lipoprotein metabolic syndrome
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 258
Healthy volunteers: no

Brief summary:
The primary objective of this study is to compare the effect of rosuvastatin 10mg with atorvastatin 10mg after 6 weeks of treatment in the ratio of ApoB/ApoA1 in subjects with metabolic syndrome.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Rosuvastatin intervention 2: Atorvastatin
Intervention descriptions: intervention 1: 10mg intervention 2: 10mg

Protocol document: